NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » TOP 50 Pharmas back to previous page show list
Eli Lilly & Co »04/05/2007 [Company watch]
Lilly Announces Senior Leadership Changes

Alex M. Azar II to join Lilly as senior vice president of corporate affairs and communications; Anne Nobles to assume role of chief compliance officer


Eli Lilly and Company

Alex M. Azar II will be joining Lilly as senior vice president of

corporate affairs and communications, reporting directly to chairman and

chief executive officer Sidney Taurel. He will be a member of the company's

policy and strategy committee, the corporate operations committee, and the

senior management council.

Azar will lead the company's teams that are responsible for

international, federal, and state government affairs, public policy

planning and development, external and internal communications, corporate

branding, and community and public relations. Azar will also lead the

company's efforts in maximizing the value of health information technology

and in fighting against the spread of counterfeit medicines.

Azar brings to Lilly a distinguished record of achievement in both the

public and private sectors. Until February 3, 2007, he was the United

States Deputy Secretary of Health and Human Services (HHS), where he worked

closely with Secretary Mike Leavitt and served for almost two years as the

chief operating officer of the largest civilian department in the federal

government. Azar supervised all operations of the HHS, including the

regulation of food and drugs, Medicare, Medicaid, medical research, public

health, welfare, child and family services, disease prevention, Indian

health, mental health services, emergency preparedness and response, and

many other activities. Agencies under his direction included, among others,

the Food and Drug Administration, the Centers for Medicare and Medicaid

Services, the National Institutes of Health, and the Centers for Disease

Control and Prevention. He was a key member of President Bush's leadership

team, contributing extensive policy, legal, and management expertise.

Prior to his tenure as Deputy Secretary, Azar served for four years as

the General Counsel of the HHS. Before entering the government, he was a

partner at the Washington, D.C., law firm of Wiley, Rein & Fielding. Azar

also clerked at the Supreme Court of the United States for Associate

Justice Antonin Scalia. He is a graduate of Dartmouth College and Yale Law

School, and will be moving to Indianapolis with his wife Jennifer and their

two young children.

"We are very pleased to have someone of Alex's caliber join the

leadership team here at Lilly," said Taurel. "He brings a combination of

distinguished government service and private practice, and he has a track

record of strong leadership. Alex has been a leading advocate for the role

that pharmaceuticals play in preventing, treating and curing disease, and

he will be a great addition to the company."

Said Azar, "After leaving public service back in February, I began to

consider ways I could continue to play an active role in the healthcare

arena. Lilly is providing me an excellent opportunity to do just that. I am

excited about joining the company's leadership team, and I look forward to

contributing to the company's efforts to bring innovative medicines to

patients around the world. The pharmaceutical industry operates in a

challenging environment, and I am anxious to begin addressing many of those

challenges through this new role."

The company also announced that Anne Nobles will assume the role of

vice president for compliance and enterprise risk management, and she will

serve as Lilly's chief compliance officer. Nobles, a graduate of Harvard

University and Georgetown University Law School, has been with Lilly for

over 16 years and has held a variety of leadership roles in public affairs,

regulatory affairs, public policy, business customer strategies, product

team leadership, and corporate affairs. Nobles will report directly to

Taurel and will be a member of both the corporate operations committee and

the senior management council.

Said Taurel, "Anne's legal background and her broad experiences here at

Lilly make her the ideal person to assume the role of the company's chief

compliance officer. We are committed to conducting ourselves with integrity

and to being in compliance with all laws and regulations, and having

someone with Anne's qualifications in this important role is evidence of

this commitment."

Lilly, a leading innovation-driven corporation, is developing a growing

portfolio of first-in-class and best-in-class pharmaceutical products by

applying the latest research from its own worldwide laboratories and from

collaborations with eminent scientific organizations. Headquartered in

Indianapolis, Ind., Lilly provides answers -- through medicines and

information -- for some of the world's most urgent medical needs.

Additional information about Lilly is available at


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.